Apyx Medical Corporation APYX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $55.9M+18.2% | $52.84M+9.9% | $47.9M-1.3% | $46.51M-5.1% | $47.29M-6.3% | ||
| -$9.08M+54.9% | -$11.11M+52.8% | -$14.52M+49.0% | -$17.29M+39.0% | -$20.11M+11.8% | ||
| -16.2%+26.3pp | -21%+27.9pp | -30.3%+28.3pp | -37.2%+20.7pp | -42.5%+2.7pp | ||
| $55.9M+18.2% | $52.84M+9.9% | $47.9M-1.3% | $46.51M-5.1% | $47.29M-6.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Apyx Medical Corporation's revenue?
- Apyx Medical Corporation (APYX) generated $55.9M in revenue over the trailing twelve months, up 18.2% year over year.
- Is Apyx Medical Corporation profitable?
- Apyx Medical Corporation is not currently profitable: it reported a net loss of $9.1M over the trailing twelve months, a -16.2% net margin.
- What are Apyx Medical Corporation's profit margins?
- Gross margin is 61.9% and operating margin is -46.0%, with a -16.2% net margin.
- Where does Apyx Medical Corporation's income statement data come from?
- Every line is extracted from Apyx Medical Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
